DLD Asset Management »

Karyopharm Therapeutics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 182k 9.75

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Marathon Digital Holdings In Put Option (MARA)
Eli Lilly & Co. Call Option (LLY)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Encore Cap Group Note 4.000% 3/1 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Super Micro Computer Com New Put Option (SMCI)
Merit Med Sys Note 3.000% 2/0 (Principal)

View all positions for DLD Asset Management

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics